Lee Hlad, DPM
Foot & Ankle Surgery · Gahanna, OHNPI 1508175449
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $316,890 of the $439,961 with a category attached, or 72.0%. Paragon 28, Inc. accounts for 66.2% of it on its own, with 25 other manufacturers making up the rest. Among foot & ankle surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $1466.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$291K
- Vilex LLC$73K
- New Standard Device, LLC Dba Metalogix$37K
- Treace Medical Concepts, Inc.$20K
- International Life Sciences$11K
- Avitus Orthopaedics, Inc.$3K
- plus $4K from 20 others
What the payments were for
- Royalty or licence$44,17010%
- Consulting fees$316,89072%
- Travel & lodging$68,26516%
- Food & beverage$9,7932%
- Education$8430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 180 | $291,424 |
| Vilex LLC | 57 | $72,639 |
| New Standard Device, LLC Dba Metalogix | 4 | $37,266 |
| Treace Medical Concepts, Inc. | 19 | $19,919 |
| International Life Sciences | 7 | $11,204 |
| Avitus Orthopaedics, Inc. | 3 | $3,024 |
| Acelrx Pharmaceuticals, Inc. | 1 | $1,200 |
| Trimed, Inc. | 1 | $1,000 |
| Organogenesis Inc. | 5 | $616 |
| Team 1, LLC | 1 | $482 |
| CDC Medical LLC | 1 | $361 |
| Nuvasive Specialized Orthopedics, Inc. | 1 | $164 |
| Stryker | 2 | $156 |
| Bone Support Inc. | 1 | $155 |
| Bioventus LLC | 3 | $62 |
| Linvatec Corporation | 1 | $51 |
| Amgen | 3 | $44 |
| Smith+Nephew | 2 | $33 |
| Osteomed LLC | 1 | $26 |
| Abbott | 1 | $24 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Bonalive Inc | 1 | $21 |
| Medline Industries LP | 1 | $19 |
| Sanara Medtech Inc. | 1 | $18 |
| Tenex Health Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$131,297
- Product Portfolio$73,432
- DYNEX$51,094
- Lapiplasty System$14,313
- REDEMPTION$13,663
- MONKEY RINGS$12,649
- FLEXBAND$10,247
- APEX 3D$6,359
- LAPIPLASTY SYSTEM 1$5,400
- REDEMPTION - R&D$4,712
- TRAUMA$2,220
- DSUVIA$1,200
- HINTERMANN$1,032
- PuraPly$528
- CHARCOT$500
- PHANTOM$226
- PRECICE Intramedullary Limb Lengthening System$164
- CERAMENTBONE VOID FILLER$155
- CERAMENT G$155
- HOFFMANN$118
How this compares
$439,961 in reported general payments places this provider in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 13 | $3,934 |
| Ammonium Lactate | 44 | $834 |
| Gentamicin Sulfate | 19 | $796 |
| Mupirocin | 73 | $586 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $483 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 39 | $384 |
| Gabapentin | 22 | $377 |
| Ketoconazole | 29 | $370 |
| Terbinafine Hcl | 11 | $358 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $338 |
| Cephalexin | 37 | $247 |
| Clindamycin Hcl | 26 | $231 |
| Doxycycline Hyclate | 28 | $198 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $103 |
| Meloxicam | 16 | $76 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $33 | $3,93413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 429 foot & ankle surgery providers in Ohio.
Other foot & ankle surgery in Gahanna
- Jonathan FeibelGahanna$1.4M
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Mark PrisselWorthington$1.2M
- Windy ColeKent$431K
- Elizabeth HewittGrove City$414K
- Dominic RizzoBlue Ash$303K
- Coleman CloughertyParma$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.